Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides
- 1 May 2008
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 126 (1), 53-61
- https://doi.org/10.1016/j.ijcard.2007.03.116
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Brachial Artery Flow-Mediated Dilation and Myocardial Perfusion in Patients With Cardiac Syndrome XThe American Journal of Cardiology, 2005
- Role of Endothelial Dysfunction in AtherosclerosisCirculation, 2004
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectinCurrent Opinion in Lipidology, 2002
- Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart DiseaseCirculation, 2000
- Novel Modulator for Endothelial Adhesion MoleculesCirculation, 1999
- Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in ObesityBiochemical and Biophysical Research Communications, 1999
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- The Endothelium — Modulator of Vascular Smooth-Muscle ToneThe New England Journal of Medicine, 1988